Administrative Coding in Electronic Health Care Record‐Based Research of NAFLD: An Expert Panel Consensus Statement-Reference-Cited by-同舟云学术

Administrative Coding in Electronic Health Care Record‐Based Research of NAFLD: An Expert Panel Consensus Statement

Published:2021-06-22 Issue:1 Volume:74 Page:474-482
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Hagström Hannes¹²³^ORCID,Adams Leon A.⁴^ORCID,Allen Alina M.⁵^ORCID,Byrne Christopher D.⁶⁷^ORCID,Chang Yoosoo⁸,Grønbæk Henning⁹^ORCID,Ismail Mona¹⁰¹¹,Jepsen Peter⁹,Kanwal Fasiha¹²,Kramer Jennifer¹²^ORCID,Lazarus Jeffrey V.¹³^ORCID,Long Michelle T.¹⁴^ORCID,Loomba Rohit¹⁵,Newsome Philip N.¹⁶¹⁷^ORCID,Rowe Ian A.¹⁸^ORCID,Ryu Seungho⁸¹⁹,Schattenberg Jörn M.²⁰^ORCID,Serper Marina²¹,Sheron Nick²²,Simon Tracey G.²³²⁴^ORCID,Tapper Elliot B.²⁵^ORCID,Wild Sarah²⁶,Wong Vincent Wai‐Sun²⁷^ORCID,Yilmaz Yusuf²⁸²⁹,Zelber‐Sagi Shira³⁰,Åberg Fredrik³¹³²^ORCID

Affiliation:

1. Division of Hepatology Department of Upper GI Karolinska University Hospital Stockholm Sweden

2. Clinical Epidemiology Unit Department of Medicine Solna Karolinska Institutet Stockholm Sweden

3. Department of Medicine Huddinge Karolinska Institutet Stockholm Sweden

4. Medical School University of Western Australia Perth WA Australia

5. Division of Gastroenterology and Hepatology Mayo Clinic Rochester MN

6. Nutrition and Metabolism Faculty of Medicine University of Southampton Southampton United Kingdom

7. Southampton National Institute for Health Research Biomedical Research Centre University Hospital Southampton Southampton General Hospital Southampton United Kingdom

8. Center for Cohort Studies Total Healthcare Center Kangbuk Samsung Hospital Sungkyunkwan University School of Medicine Seoul Republic of Korea

9. Department of Hepatology and Gastroenterology Aarhus University Hospital Aarhus Denmark

10. Division of Gastroenterology Department of Internal Medicine King Fahad Hospital of the University Al‐Khobar Saudi Arabia

11. College of Medicine Imam Abdulrahman Bin Faisal University Dammam Saudi Arabia

12. Baylor College of Medicine and Michael E. DeBakey VA Medical Center Houston TX

13. Barcelona Institute for Global Health (ISGlobal) Hospital Clínic University of Barcelona Barcelona Spain

14. Department of Medicine Section of Gastroenterology Boston University School of Medicine Boston MA

15. NAFLD Research Center Division of Gastroenterology and Epidemiology University of California at San Diego La Jolla CA

16. National Institute for Health Research Biomedical Research Centre at University Hospitals Birmingham NHS Foundation Trust University of Birmingham Birmingham United Kingdom

17. Centre for Liver and Gastrointestinal Research Institute of Immunology and Immunotherapy University of Birmingham Birmingham United Kingdom

18. Leeds Institute for Medical Research University of Leeds Leeds United Kingdom

19. Department of Clinical Research Design and Evaluation SAIHST Sungkyunkwan University Seoul Republic of Korea

20. Metabolic Liver Research Program, I. Department of Medicine University Medical Center of the Johannes Gutenberg‐University Mainz Germany

21. Division of Gastroenterology and Hepatology Department of Medicine University of Pennsylvania Perelman School of Medicine Philadelphia PA

22. Foundation for Liver Research London United Kingdom

23. Division of Gastroenterology and Hepatology Massachusetts General Hospital Boston MA

24. Harvard Medical School Boston MA

25. Division of Gastroenterology and Hepatology University of Michigan Ann Arbor MI

26. Usher Institute University of Edinburgh Edinburgh United Kingdom

27. Department of Medicine and Therapeutics The Chinese University of Hong Kong Hong Kong

28. Liver Research Unit Institute of Gastroenterology Marmara University Istanbul Turkey

29. Department of Gastroenterology School of Medicine Marmara University Istanbul Turkey

30. School of Public Health University of Haifa Haifa Israel

31. Transplantation and Liver Surgery Clinic Helsinki University Hospital Helsinki Finland

32. University of Helsinki Helsinki Finland

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.31726

Reference34 articles.

1. Beyond randomized controlled trials: A critical comparison of trials with nonrandomized studies

2. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up

3. The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years

4. Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD

5. Prognosis of patients with a diagnosis of fatty liver—a registry‐based cohort study;Jepsen P;Hepatogastroenterology,2003

Cited by 137 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk of hepatic events associated with use of sodium-glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists, and thiazolidinediones among patients with metabolic dysfunction-associated steatotic liver disease;Gut;2024-09-06

2. Accurate prediction of all-cause mortality in patients with metabolic dysfunction-associated steatotic liver disease using electronic health records;Annals of Hepatology;2024-09

3. Disparities in metabolic dysfunction-associated steatotic liver disease and cardiometabolic conditions in low and lower middle-income countries: a systematic analysis from the global burden of disease study 2019;Metabolism;2024-09

4. Cost burden of cirrhosis and liver disease progression in metabolic dysfunction–associated steatohepatitis: A US cohort study;Journal of Managed Care & Specialty Pharmacy;2024-09

5. Sodium‐glucose co‐transporter‐2 inhibitors versus dipeptidyl peptidase‐4 inhibitors on major liver outcomes in metabolic dysfunction‐associated steatotic liver disease;Diabetes, Obesity and Metabolism;2024-08-12